摘要
目的评价免疫表型测定在骨髓增生异常综合征(MDS)诊断及预后判断中的价值。方法应用一组单克隆抗体采用免疫荧光法对32例MDS患者骨髓单个核细胞(MNC)进行免疫表型检测。结果MDS患者髓系抗原表达明显增高,淋巴细胞抗原表达相对减少,而且随MDS恶化,FAB亚型的抗原表达出现规律性变化,随RA/RAS向RAEB再向RABEt转化,较早期的髓系抗原(如CD13、CD33)逐渐增加,较晚期出现的髓系抗原逐渐减少,同时伴有T淋巴细胞抗原表达减少;RA/RAS阶段骨髓CD34+细胞与正常组相比无显著增高,RAEB和RAEBt阶段CD34+细胞数明显增高;较早期骨髓细胞(即祖细胞)表面抗原CD38、HLADR、CD99R、CD9在MDS表达明显增加。CD34和其它早期抗原表达增高者,预后较差,易于转化为白血病。结论MDS患者骨髓MNC表面标记的检测有利于MDS的诊断,也可协助预后判断。
Objective To evaluate the values of immunophenotyping in the
diagnosis and prognosis of myelodysplastic syndromes(MDS). Methods Surface markers of
mononuclear marrow cells were analyzed by indirect immunofluorescence for a panel of
monoclonal antibodies in 32 patients with MDS. Results Expression of myeloid antigen
increased significantly while lymphoid antigen decreased. The antigen expression was
correlated with the FAB subtype of MDS, Immature myeloid cells (CD 13 +,CD 33 +) was
being increased and the lymphoid antigen expression decreased with the RA/RAS evolving to
RAEB and RAEB t.Compared with normal marrow, the number of CD 34 + cells was not
significantly different in RA/RAS subtypes but significantly higher in RAEB/RAEB t subtypes.
The expression of early marrow cell antigens(CD 38 ,HLA DR,CD 99R and CD 9) was
significantly increased. The expression of CD 34 and other early antigen was predictive for
transformation and poor survival. Conclusion Surface marker analysis of mononuclear marrow
cells may be a useful tool for the diagnosis and prognosis of MDS.
出处
《中华血液学杂志》
CAS
CSCD
北大核心
1999年第1期14-16,共3页
Chinese Journal of Hematology
基金
天津自然科学基金
中国医学科学院基金